- Development of AFFITOPE vaccines for Alzheimer's disease (AD)--from concept to clinical testingA Schneeberger
AFFiRiS, Viehmarktgasse 2A, A 1030 Vienna, Austria
J Nutr Health Aging 13:264-7. 2009..Further clinical testing will focus on the identification of the optimal vaccine dose and immunization schedule. Together, result of these trials will provide a solid basis for clinical POC studies...
- AFFITOME® technology in neurodegenerative diseases: the doubling advantageAchim Schneeberger
AFFiRiS AG, Vienna, Austria
Hum Vaccin 6:948-52. 2010....
- Vaccination for Parkinson's diseaseA Schneeberger
AFFiRiS AG, Karl Farkas Gasse 22, A 1030 Vienna, Austria
Parkinsonism Relat Disord 18:S11-3. 2012..PD01, the first in class aSyn vaccine developed by AFFiRiS is about to enter the clinical phase of development...